Background: The optimal procedures to prevent, identify, monitor, and treat long-term pulmonary sequelae of COVID-19 are elusive. Here, we characterized the kinetics of respiratory and symptom recovery following COVID-19. Methods: We conducted a longitudinal, multicenter observational study in ambulatory and hospitalized COVID-19 patients recruited in early 2020 (n = 145). Pulmonary computed tomography (CT) and lung function (LF) readouts, symptom prevalence, and clinical and laboratory parameters were collected during acute COVID-19 and at 60, 100, and 180 days follow-up visits. Recovery kinetics and risk factors were investigated by logistic regression. Classification of clinical features and participants was accomplished by unsupervised and semi-supervised multiparameter clustering and machine learning. Results: At the 6-month follow-up, 49% of participants reported persistent symptoms. The frequency of structural lung CT abnormalities ranged from 18% in the mild outpatient cases to 76% in the intensive care unit (ICU) convalescents. Prevalence of impaired LF ranged from 14% in the mild outpatient cases to 50% in the ICU survivors. Incomplete radiological lung recovery was associated with increased anti-S1/S2 antibody titer, IL-6, and CRP levels at the early follow-up. We demonstrated that the risk of perturbed pulmonary recovery could be robustly estimated at early follow-up by clustering and machine learning classifiers employing solely non-CT and non-LF parameters. Conclusions: The severity of acute COVID-19 and protracted systemic inflammation is strongly linked to persistent structural and functional lung abnormality. Automated screening of multiparameter health record data may assist in the prediction of incomplete pulmonary recovery and optimize COVID-19 follow-up management. Funding: The State of Tyrol (GZ 71934), Boehringer Ingelheim/Investigator initiated study (IIS 1199-0424). Clinical trial number: ClinicalTrials.gov: NCT04416100.
Background: The optimal procedures to prevent, identify, monitor, and treat long-term pulmonary sequelae of COVID-19 are elusive. Here, we characterized the kinetics of respiratory and symptom recovery following COVID-19. Methods: We conducted a longitudinal, multicenter observational study in ambulatory and hospitalized COVID-19 patients recruited in early 2020 (n = 145). Pulmonary computed tomography (CT) and lung function (LF) readouts, symptom prevalence, and clinical and laboratory parameters were collected during acute COVID-19 and at 60, 100, and 180 days follow-up visits. Recovery kinetics and risk factors were investigated by logistic regression. Classification of clinical features and participants was accomplished by unsupervised and semi-supervised multiparameter clustering and machine learning. Results: At the 6-month follow-up, 49% of participants reported persistent symptoms. The frequency of structural lung CT abnormalities ranged from 18% in the mild outpatient cases to 76% in the intensive care unit (ICU) convalescents. Prevalence of impaired LF ranged from 14% in the mild outpatient cases to 50% in the ICU survivors. Incomplete radiological lung recovery was associated with increased anti-S1/S2 antibody titer, IL-6, and CRP levels at the early follow-up. We demonstrated that the risk of perturbed pulmonary recovery could be robustly estimated at early follow-up by clustering and machine learning classifiers employing solely non-CT and non-LF parameters. Conclusions: The severity of acute COVID-19 and protracted systemic inflammation is strongly linked to persistent structural and functional lung abnormality. Automated screening of multiparameter health record data may assist in the prediction of incomplete pulmonary recovery and optimize COVID-19 follow-up management. Funding: The State of Tyrol (GZ 71934), Boehringer Ingelheim/Investigator initiated study (IIS 1199-0424). Clinical trial number: ClinicalTrials.gov: NCT04416100.
Authors: Hiroto Hatabu; Gary M Hunninghake; Luca Richeldi; Kevin K Brown; Athol U Wells; Martine Remy-Jardin; Johny Verschakelen; Andrew G Nicholson; Mary B Beasley; David C Christiani; Raúl San José Estépar; Joon Beom Seo; Takeshi Johkoh; Nicola Sverzellati; Christopher J Ryerson; R Graham Barr; Jin Mo Goo; John H M Austin; Charles A Powell; Kyung Soo Lee; Yoshikazu Inoue; David A Lynch Journal: Lancet Respir Med Date: 2020-07 Impact factor: 30.700
Authors: M Elizabeth Wilcox; Demetris Patsios; Grainne Murphy; Paul Kudlow; Narinder Paul; Catherine M Tansey; Leslie Chu; Andrea Matte; George Tomlinson; Margaret S Herridge Journal: Chest Date: 2013-04 Impact factor: 9.410
Authors: Carole H Sudre; Karla A Lee; Mary Ni Lochlainn; Thomas Varsavsky; Benjamin Murray; Mark S Graham; Cristina Menni; Marc Modat; Ruth C E Bowyer; Long H Nguyen; David A Drew; Amit D Joshi; Wenjie Ma; Chuan-Guo Guo; Chun-Han Lo; Sajaysurya Ganesh; Abubakar Buwe; Joan Capdevila Pujol; Julien Lavigne du Cadet; Alessia Visconti; Maxim B Freidin; Julia S El-Sayed Moustafa; Mario Falchi; Richard Davies; Maria F Gomez; Tove Fall; M Jorge Cardoso; Jonathan Wolf; Paul W Franks; Andrew T Chan; Tim D Spector; Claire J Steves; Sébastien Ourselin Journal: Sci Adv Date: 2021-03-19 Impact factor: 14.136
Authors: Hossein Estiri; Zachary H Strasser; Gabriel A Brat; Yevgeniy R Semenov; Chirag J Patel; Shawn N Murphy Journal: BMC Med Date: 2021-09-27 Impact factor: 11.150
Authors: Hannah E Davis; Gina S Assaf; Lisa McCorkell; Hannah Wei; Ryan J Low; Yochai Re'em; Signe Redfield; Jared P Austin; Athena Akrami Journal: EClinicalMedicine Date: 2021-07-15
Authors: Javier Perez-Saez; Stephen A Lauer; Laurent Kaiser; Simon Regard; Elisabeth Delaporte; Idris Guessous; Silvia Stringhini; Andrew S Azman Journal: Lancet Infect Dis Date: 2020-07-14 Impact factor: 25.071
Authors: Thomas Sonnweber; Philipp Grubwieser; Sabina Sahanic; Anna Katharina Böhm; Alex Pizzini; Anna Luger; Christoph Schwabl; Sabine Koppelstätter; Katharina Kurz; Bernhard Puchner; Barbara Sperner-Unterweger; Katharina Hüfner; Ewald Wöll; Manfred Nairz; Gerlig Widmann; Ivan Tancevski; Judith Löffler-Ragg; Günter Weiss Journal: Metabolites Date: 2022-06-14
Authors: Justin Reese; Hannah Blau; Timothy Bergquist; Johanna J Loomba; Tiffany Callahan; Bryan Laraway; Corneliu Antonescu; Elena Casiraghi; Ben Coleman; Michael Gargano; Kenneth Wilkins; Luca Cappelletti; Tommaso Fontana; Nariman Ammar; Blessy Antony; T M Murali; Guy Karlebach; Julie A McMurry; Andrew Williams; Richard Moffitt; Jineta Banerjee; Anthony E Solomonides; Hannah Davis; Kristin Kostka; Giorgio Valentini; David Sahner; Christopher G Chute; Charisse Madlock-Brown; Melissa A Haendel; Peter N Robinson Journal: medRxiv Date: 2022-05-25